Skip to main content
. 2024 May 13;10(10):e30685. doi: 10.1016/j.heliyon.2024.e30685

Table 1.

Cohort characteristics (n = 154).

sPTB (n = 26)
no sPTB (n = 128)
Missing
n % n % n %
Gestational age at inclusion (mean, sd) 12.5 1.6 13.0 2.1
Age (mean, SD) 32.7 3.9 32.4 4.5
Ethnicity 4 2.6
 White European 14 53.8 55 44.4
 African 3 11.5 26 21.0
 Surinamese 1 3.8 13 10.5
 Turkish 2 7.7 4 3.2
 Indian 0 5 4.0
 Other Asian 3 11.5 2 1.6
 Hispanic 1 3.8 4 3.2
 Mixed 2 7.7 12 9.7
 Other 0 3 2.4
Smoking during entire pregnancy 0 3 2.3
BMI (median, IQR) 24.8 20.5–28.8 24.2 21.8–28.6 3 1.9
Previous sexually transmitted infections
 Chlamydia trachomatis 4 15.4 14 10.9
 Neisseria gonorrhoeae 2 7.7 1 0.8
Parity
 1 17 65.4 65 50.8
 2 3 11.5 34 26.6
 ≥3 6 23.0 29 22.6
Previous preterm delivery
 <23 + 0 weeks of gestation 5 19.2 45 35.2
 <28+0weeks of gestation 10 38.5 39 30.5
Interpregnancy interval in months
 <6 months 8 30.8 28 21.9
 6–12 months 4 15.4 25 19.5
 >12 months 14 53.8 75 58.6
ART current pregnancy
 IUI 0 1 0.8
 IVF 3 11.5 3 2.3
 ICSI 1 3.8 9 7.0
Bacterial vaginosis screening
 receiving treatment 7 26.9 40 31.3
 vaginal complaints during first trimester 1 3.8 4 3.1
Preventive therapies
 Progesterone 24 92.3 117 93.6 3* 1.9
 Cervical cerclage placed transvaginally during pregnancy 5 19.2 26 20.3 4* 2.6
 Cervical cerclage placed transabdominally pre-pregnancy 0 3 2.3 4* 2.6
 Cervical pessary 3 11.5 5 3.9
Cervical length < 25 mm 7 26.9 18 14.1 18** 11.7
Twin pregnancy 3 11.5 2 1.6 6* 3.8
Timing of delivery 1 0.6
 Spontaneous miscarriage <16+0 weeks 0 2 1.6
 Termination for congenital anomalies 0 3 2.3
 Late miscarriage (16–22+6 weeks of gestation) 2 7.7 0
 Spontaneous preterm birth (23+0–36+6 weeks of gestation) 24 92.3 0
 medically indicated preterm birth 23+0–36+6 weeks of gestation) 0 8 6.3
 Term birth (>37+0 weeks of gestation) 0 114 89.8

SD: standard deviation. IQR: interquartile range. *including miscarriages <16 + 0 weeks of gestation and pregnancy terminations. **including miscarriages <16 + 0 weeks of gestation and pregnancy terminations and participants with cervical cerclage or pessary in situ before start routine cervical length measurements.